RPRX logo

Royalty Pharma (RPRX) Operating profit

annual operating profit:

$1.29B-$199.71M(-13.38%)
December 31, 2024

Summary

  • As of today (May 19, 2025), RPRX annual operating income is $1.29 billion, with the most recent change of -$199.71 million (-13.38%) on December 31, 2024.
  • During the last 3 years, RPRX annual operating profit has fallen by -$138.27 million (-9.66%).
  • RPRX annual operating profit is now -50.73% below its all-time high of $2.62 billion, reached on December 31, 2019.

Performance

RPRX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

quarterly operating profit:

$534.18M+$172.67M(+47.76%)
March 31, 2025

Summary

  • As of today (May 19, 2025), RPRX quarterly operating income is $534.18 million, with the most recent change of +$172.67 million (+47.76%) on March 31, 2025.
  • Over the past year, RPRX quarterly operating profit has increased by +$607.96 million (+824.08%).
  • RPRX quarterly operating profit is now -59.89% below its all-time high of $1.33 billion, reached on December 31, 2019.

Performance

RPRX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

TTM operating profit:

$1.90B+$607.96M(+47.04%)
March 31, 2025

Summary

  • As of today (May 19, 2025), RPRX TTM operating income is $1.90 billion, with the most recent change of +$607.96 million (+47.04%) on March 31, 2025.
  • Over the past year, RPRX TTM operating profit has increased by +$961.00 million (+102.30%).
  • RPRX TTM operating profit is now -27.88% below its all-time high of $2.64 billion, reached on June 30, 2020.

Performance

RPRX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

RPRX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.4%+824.1%+102.3%
3 y3 years-9.7%+143.1%+33.7%
5 y5 years-50.7%+47.8%-25.6%

RPRX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.4%+40.0%-27.3%+824.1%at high+105.9%
5 y5-year-50.7%+40.0%-28.3%+824.1%-27.9%+105.9%
alltimeall time-50.7%+40.0%-59.9%+824.1%-27.9%+341.0%

RPRX Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$534.18M(+47.8%)
$1.90B(+47.0%)
Dec 2024
$1.29B(-13.4%)
$361.51M(-50.8%)
$1.29B(-16.3%)
Sep 2024
-
$735.07M(+172.6%)
$1.54B(+60.8%)
Jun 2024
-
$269.63M(-465.5%)
$960.19M(+2.2%)
Mar 2024
-
-$73.77M(-112.0%)
$939.40M(-37.0%)
Dec 2023
$1.49B(+61.7%)
$612.90M(+304.7%)
$1.49B(+47.4%)
Sep 2023
-
$151.44M(-39.1%)
$1.01B(-3.9%)
Jun 2023
-
$248.84M(-48.0%)
$1.05B(-10.9%)
Mar 2023
-
$478.97M(+259.7%)
$1.18B(+28.1%)
Dec 2022
$922.89M(-35.5%)
$133.17M(-30.7%)
$922.89M(-2.1%)
Sep 2022
-
$192.21M(-49.1%)
$943.14M(-10.5%)
Jun 2022
-
$377.79M(+71.9%)
$1.05B(-25.8%)
Mar 2022
-
$219.72M(+43.2%)
$1.42B(-0.7%)
DateAnnualQuarterlyTTM
Dec 2021
$1.43B(-13.8%)
$153.42M(-49.4%)
$1.43B(-13.6%)
Sep 2021
-
$303.05M(-59.3%)
$1.66B(-11.1%)
Jun 2021
-
$744.95M(+224.9%)
$1.86B(+22.0%)
Mar 2021
-
$229.30M(-39.5%)
$1.53B(-8.0%)
Dec 2020
$1.66B(-36.7%)
$379.11M(-25.7%)
$1.66B(-36.5%)
Sep 2020
-
$510.57M(+24.7%)
$2.61B(-0.8%)
Jun 2020
-
$409.35M(+13.3%)
$2.64B(+3.2%)
Mar 2020
-
$361.43M(-72.9%)
$2.55B(-2.6%)
Dec 2019
$2.62B(+92.3%)
$1.33B(+150.1%)
$2.62B(+103.1%)
Sep 2019
-
$532.50M(+62.4%)
$1.29B(+70.2%)
Jun 2019
-
$327.86M(-23.9%)
$758.76M(+76.1%)
Mar 2019
-
$430.90M
$430.90M
Dec 2018
$1.36B(+45.2%)
-
-
Dec 2017
$939.69M
-
-

FAQ

  • What is Royalty Pharma annual operating income?
  • What is the all time high annual operating profit for Royalty Pharma?
  • What is Royalty Pharma annual operating profit year-on-year change?
  • What is Royalty Pharma quarterly operating income?
  • What is the all time high quarterly operating profit for Royalty Pharma?
  • What is Royalty Pharma quarterly operating profit year-on-year change?
  • What is Royalty Pharma TTM operating income?
  • What is the all time high TTM operating profit for Royalty Pharma?
  • What is Royalty Pharma TTM operating profit year-on-year change?

What is Royalty Pharma annual operating income?

The current annual operating profit of RPRX is $1.29B

What is the all time high annual operating profit for Royalty Pharma?

Royalty Pharma all-time high annual operating income is $2.62B

What is Royalty Pharma annual operating profit year-on-year change?

Over the past year, RPRX annual operating income has changed by -$199.71M (-13.38%)

What is Royalty Pharma quarterly operating income?

The current quarterly operating profit of RPRX is $534.18M

What is the all time high quarterly operating profit for Royalty Pharma?

Royalty Pharma all-time high quarterly operating income is $1.33B

What is Royalty Pharma quarterly operating profit year-on-year change?

Over the past year, RPRX quarterly operating income has changed by +$607.96M (+824.08%)

What is Royalty Pharma TTM operating income?

The current TTM operating profit of RPRX is $1.90B

What is the all time high TTM operating profit for Royalty Pharma?

Royalty Pharma all-time high TTM operating income is $2.64B

What is Royalty Pharma TTM operating profit year-on-year change?

Over the past year, RPRX TTM operating income has changed by +$961.00M (+102.30%)
On this page